Captopril EP Impurity O

IMPURITIES

Product Details

CAT No.# CS-EO-00114
Category Impurities
CAS NA
Molecular Weight 474.63
Molecular Formula C21H34N2O6S2
Purity: >98
Synonyms: (2S,2'S)-1,1'-((2S,2'S)-3,3'-(propane-2,2-diylbis(sulfanediyl))bis(2-methylpropanoyl))bis(pyrrolidine-2-carboxylic acid); 1,1′-[Propane-2,2-diylbis[sulfanediyl[(2S)-2-methyl-1-oxopropane-3,1-diyl]]]bis[(2S)-pyrrolidine-2-carboxylic]acid
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. Rigosertib deuterated
2. (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-5-(((S)-tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diol
3. (1R,2R)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(((S)- 2-hydroxy-1-phenylethyl)amino)-3-(pyrrolidin-1-yl)propan- 1-ol
4. (2S,3S,4R,5R,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-((((S)-tetrahydrofuran-3-yl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-triol
5. (1R,2R)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-octanamido-3-(pyrrolidin-1-yl)propyl octanoate
6. Eliglustat-N-Oxide
7. 3-((5-chloro-4-(pyridin-3-yl)pyrimidin-2-yl)amino)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide
8. Eliglustat Heptanoic acid
9. Eliglustat (1S,2R) and (1R,2S)-Diastereomers
10. Eliglustat-DBC Amide
11. Nystatin A2
12. N-((1R,2S)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1- hydroxy- 3-oxo-3-(pyrrolidin-1-yl) propan-2-yl)octanamide
13. Eliglustat Decanoic acid
14. 2-(2-aminoethyl)benzenesulfonamide hydrochloride
15. Atomoxetine Hydrochloride (1044469)
16. 1,3-Dibromo-2,3-dimethylbutane
17. Atenolol (1044403)
18. Idarubicin TFA acetate
19. 2,4,5-Trichlorobiphenyl
20. Bupropion Hydrochloride (1078733)


SMILES:
O=C([C@H]1N(C([C@H](C)CSC(C)(C)SC[C@@H](C)C(N2[C@H](C(O)=O)CCC2)=O)=O)CCC1)O



This page contains information about Captopril EP Impurity O Cas NA and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."